General MedicationsINJECTIONStandard
ENALAPRILAT
ENALAPRILAT
Standard Dose
1.25MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary
Approval overview ENALAPRILAT is listed in Drugs@FDA under application 078687 (ANDA).
Marketing status: Prescription Active ingredient ENALAPRILAT Form and strength INJECTABLE;INJECTION - 1.25MG/ML Sponsor HIKMA FARMACEUTICA Submission history Latest submission status date: 2010-09-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview ENALAPRILAT is listed in Drugs@FDA under application 078687 (ANDA). Marketing status: Prescription Active ingredient ENALAPRILAT Form and strength INJECTABLE;INJECTION - 1.25MG/ML Sponsor HIKMA FARMACEUTICA Submission history Latest submission status date: 2010-09-27 00:00:00. Submission type: SUPPL.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.